German chemicals and pharmaceuticals giant Bayer said Thursday it would slash 12,000 jobs in a major restructuring following the takeover of Monsanto, enabling it to save 2.6 billion euros ($3 billion) a year from 2022.
The planned job cuts will affect about one in every ten of the group's 118,200 posts, "a significant number of them in Germany", said the group in a statement.
Bayer swallowed Monsanto in one of Germany's biggest ever corporate takeovers at a cost of 63 billion euros in June.
But barely two months later, a court ruling in the US left Bayer with multi-million-dollar damages to pay as the judge found that its newly acquired subsidiary Monsanto should have warned a user about cancer risks from its herbicide Roundup.
Announcing the restructuring on Thursday, Bayer said it planned to exit its animal health business, in order to concentrate resources on its core businesses of pharmaceuticals, consumer health and crop science.
In digesting Monsanto, it is its crop science division that will be among the hardest hit by job cuts, with 4,100 posts to go.
The company said it expected to complete trimming its staff by the end of 2021.
"These changes are necessary and lay the foundation for Bayer to enhance its performance and agility. With these measures, we aim to take full advantage of the growth potential for our businesses," said Werner Baumann, Bayer board chairman.